Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination
Cell membrane thyroid hormone (TH) transport can be facilitated by the monocarboxylate transporter 8 (MCT8), encoded by the solute carrier family 16 member 2 (SLC16A2) gene. Human mutations of the gene, SLC16A2, result in the X-linked-inherited psychomotor retardation and hypomyelination disorder, A...
Main Authors: | Jae Young Lee, Min Joung Kim, Devy Deliyanti, Michael F. Azari, Fernando Rossello, Adam Costin, Georg Ramm, Edouard G. Stanley, Andrew G. Elefanty, Jennifer L. Wilkinson-Berka, Steven Petratos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396417304140 |
Similar Items
-
Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development
by: Ferdy S. van Geest, et al.
Published: (2021-09-01) -
Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
by: Pieter Vancamp, et al.
Published: (2020-05-01) -
Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish
by: David Zada, et al.
Published: (2016-11-01) -
MCT8 Deficiency: The Road to Therapies for a Rare Disease
by: Carmen Grijota-Martínez, et al.
Published: (2020-04-01) -
A rare thyroid disorder mimicking mitochondrial disease
by: Adrijan Sarajlija, et al.
Published: (2021-06-01)